AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.45
(7.93%)
AUD 2.45
(7.93%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 194.03 Million NZD | 24.75% |
| 2023 | 156.64 Million NZD | 20.2% |
| 2022 | 130.31 Million NZD | 15.22% |
| 2021 | 113.1 Million NZD | 7.11% |
| 2020 | 105.59 Million NZD | 24.05% |
| 2019 | 85.12 Million NZD | 4.87% |
| 2018 | 81.17 Million NZD | 17.3% |
| 2017 | 69.2 Million NZD | 8.11% |
| 2016 | 64.01 Million NZD | 13.82% |
| 2015 | 56.24 Million NZD | 14.92% |
| 2014 | 48.93 Million NZD | 21.25% |
| 2013 | 40.36 Million NZD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 83.61 Million NZD | -8.01% |
| 2024 Q4 | 111.79 Million NZD | 33.71% |
| 2024 FY | 194.03 Million NZD | 23.87% |
| 2023 Q2 | 65.75 Million NZD | -12.1% |
| 2023 FY | 156.64 Million NZD | 20.2% |
| 2023 Q4 | 90.89 Million NZD | 38.24% |
| 2022 Q4 | 74.8 Million NZD | 34.75% |
| 2022 FY | 130.31 Million NZD | 15.22% |
| 2022 Q2 | 55.51 Million NZD | -13.64% |
| 2021 Q2 | 48.82 Million NZD | -16.76% |
| 2021 FY | 113.1 Million NZD | 7.11% |
| 2021 Q4 | 64.28 Million NZD | 31.67% |
| 2020 Q4 | 58.65 Million NZD | 24.93% |
| 2020 FY | 105.59 Million NZD | 24.05% |
| 2020 Q2 | 46.94 Million NZD | 0.56% |
| 2019 Q2 | 38.44 Million NZD | -13.84% |
| 2019 FY | 85.12 Million NZD | 4.87% |
| 2019 Q4 | 46.68 Million NZD | 21.45% |
| 2018 FY | 81.17 Million NZD | 17.3% |
| 2018 Q4 | 44.61 Million NZD | 22.03% |
| 2018 Q2 | 36.56 Million NZD | -7.25% |
| 2017 Q2 | 29.78 Million NZD | -13.59% |
| 2017 Q4 | 39.41 Million NZD | 32.33% |
| 2017 FY | 69.2 Million NZD | 8.11% |
| 2016 Q2 | 29.54 Million NZD | -7.93% |
| 2016 FY | 64.01 Million NZD | 13.82% |
| 2016 Q4 | 34.47 Million NZD | 16.68% |
| 2015 Q4 | 32.08 Million NZD | 32.85% |
| 2015 FY | 56.24 Million NZD | 14.92% |
| 2015 Q2 | 24.15 Million NZD | 0.0% |
| 2014 FY | 48.93 Million NZD | 21.25% |
| 2013 FY | 40.36 Million NZD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Althea Group Holdings Limited | 29.4 Million AUD | -559.957% |
| Cann Group Limited | 15.37 Million AUD | -1162.174% |
| ECS Botanics Holdings Ltd | 20.03 Million AUD | -868.7% |
| Ecofibre Limited | 27.98 Million AUD | -593.375% |
| Elixinol Wellness Limited | 8.26 Million AUD | -2246.523% |
| Hygrovest Limited | 260 Thousand AUD | -74528.462% |
| IDT Australia Limited | 13.22 Million AUD | -1367.065% |
| Invion Limited | 3.69 Million AUD | -5152.316% |
| Little Green Pharma Ltd | 19.56 Million AUD | -891.596% |
| Live Verdure Ltd | 1.93 Million AUD | -9922.345% |
| Medical Developments International Limited | 33.14 Million AUD | -485.339% |
| Vitura Health Limited | 123.87 Million AUD | -56.642% |
| Vita Life Sciences Limited | 74.16 Million AUD | -161.639% |